Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Differential expression and regulatory roles of FABP5 and FABP7 in oligodendrocyte lineage cells.
Consensus Statement on medication use in multiple sclerosis by the Spanish Society of Neurology's study group for demyelinating diseases.
Pathologic laughing as a presenting feature in a patient with neuromyelitis optica.
Gait kinematics of people with Multiple Sclerosis and the acute application of Functional Electrical Stimulation.
Beneficial Effect of Tolerogenic Dendritic Cells Pulsed with MOG Autoantigen in Experimental Autoimmune Encephalomyelitis.
DNase hypersensitive sites and association with multiple sclerosis.
Comparison of Sleep Problems in Individuals with Spinal Cord Injury and Multiple Sclerosis.
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis.
A role for human brain pericytes in neuroinflammation.
JCV epidemiology in MS (JEMS)-Epidemiology of anti-JCV antibody prevalence in multiple sclerosis patients-Portuguese data.
Treatment with the Immunomodulator FTY720 (Fingolimod) Significantly Reduces Renal Inflammation in Murine Unilateral Ureteral Obstruction.
Mutations in the PLEKHG5 gene is relevant with autosomal recessive intermediate Charcot-Marie-Tooth disease.
Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination.
Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients.
Dickkopf-3, a tissue-derived modulator of local T-cell responses.
Can somatosensory evoked potentials predict disease course in early multiple sclerosis patients?
Murine K2P5.1 Deficiency Has No Impact on Autoimmune Neuroinflammation due to Compensatory K2P3.1- and KV1.3-Dependent Mechanisms.
The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease.
Adaptive Immune Responses in CNS Autoimmune Disease: Mechanisms and Therapeutic Opportunities.
Risk of progressive multifocal leukoencephalopathy in patients with multiple sclerosis.
Combination of AIDP and pyramidal signs associated with antecedent hepatitis A infection: a rare (co)occurrence.
Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal.
Ustekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvement.
Culturing microglia from the neonatal and adult central nervous system.
Cerebrospinal fluid inflammatory markers in patients with multiple sclerosis: a pilot study.

Pages